Goldman Sachs Initiates Coverage On Medtronic with Sell Rating, Announces Price Target of $83
Portfolio Pulse from Benzinga Newsdesk
Goldman Sachs has initiated coverage on Medtronic with a Sell rating and set a price target of $83.
May 30, 2024 | 11:16 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Goldman Sachs has initiated coverage on Medtronic with a Sell rating and set a price target of $83, which is below the current market price.
The Sell rating and lower price target from a major financial institution like Goldman Sachs is likely to negatively impact Medtronic's stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100